GlobeStar Therapeutics Corp: 10-Q filed 2018-05-21

Name: GlobeStar Therapeutics Corp: 10-Q filed 2018-05-21
Creator: GlobeStar Therapeutics Corp

What GlobeStar Therapeutics Corp reported in its quarterly report filed 2018-05-21 (fiscal Q2 2018): 20 published measures, 54 facts as tagged in accession 0001185185-18-000965.

This filing

Form: 10-Q (quarterly report)
Filed: 2018-05-21
Fiscal period: fiscal Q2 2018
Accession: 0001185185-18-000965 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GlobeStar Therapeutics Corp filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2018-03-31	88,191	USD
At 2017-09-30	24,553	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2018-03-31	874,143	USD
At 2017-09-30	648,528	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2018-03-31	-785,952	USD
At 2017-09-30	-623,975	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2018-03-31	66,550	USD
At 2017-09-30	14,100	USD
At 2017-03-31	7,529	USD
At 2016-09-30	5,845	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	-40,212	USD	90
2017-10-01 to 2018-03-31	-505,562	USD	182
2017-01-01 to 2017-03-31	-195,403	USD	90
2016-10-01 to 2017-03-31	-512,816	USD	182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2017-10-01 to 2018-03-31	-47,550	USD	182
2016-10-01 to 2017-03-31	-38,316	USD	182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Unit	Days
2018-01-01 to 2018-03-31	USD	90
2017-10-01 to 2018-03-31	USD	182
2017-01-01 to 2017-03-31	USD	90
2016-10-01 to 2017-03-31	USD	182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-10-01 to 2018-03-31	100,000	USD	182
2016-10-01 to 2017-03-31	40,000	USD	182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2018-03-31	-5,687,356	USD
At 2017-09-30	-5,181,794	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2017-10-01 to 2018-03-31	0	USD	182
2016-10-01 to 2017-03-31	283,770	USD	182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	-41,724	USD	90
2017-10-01 to 2018-03-31	-170,419	USD	182
2017-01-01 to 2017-03-31	-119,863	USD	90
2016-10-01 to 2017-03-31	-356,702	USD	182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2018-03-31	74,606	USD
At 2017-09-30	14,850	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	4,019	USD	90
2017-10-01 to 2018-03-31	5,224	USD	182
2017-01-01 to 2017-03-31	75,540	USD	90
2016-10-01 to 2017-03-31	156,114	USD	182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2018-03-31	733,021	USD
At 2017-09-30	504,855	USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2018-03-31	54,584,067	shares
At 2017-09-30	45,584,067	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2018-03-31	1,851,416	USD
At 2017-09-30	1,520,658	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2018-03-31	2,912	USD
At 2017-09-30	-970	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2018-03-31	0	USD
At 2017-09-30	0	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	-38,271	USD	90
2017-10-01 to 2018-03-31	-501,680	USD	182
2017-01-01 to 2017-03-31	-195,403	USD	90
2016-10-01 to 2017-03-31	-509,905	USD	182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2018-01-01 to 2018-03-31	41,724	USD	90
2017-10-01 to 2018-03-31	170,419	USD	182
2017-01-01 to 2017-03-31	119,863	USD	90
2016-10-01 to 2017-03-31	356,702	USD	182

Inspect the source

Entity: GlobeStar Therapeutics Corp / CIK 0001502152
Captured: 2026-09-21T17:19:31.788Z
SEC response SHA-256: 6be36a03e8f75354b6b3cf653d7b4e1bb0d8a85378e8b575eedf967d0fac66f7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001502152.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))